share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 20 10:33
Summary by Moomoo AI
Vertex Pharmaceuticals Inc. officer Bastiano Sanna is set to sell 4,002 shares of common stock on 02/20/2024, with an aggregate market value of approximately $1,684,001.58. The shares to be sold were recently acquired on 02/17/2024 as part of compensation in the form of performance shares and restricted stock vesting, both from the issuer. This transaction follows a previous sale of 3,145 shares within the past three months, which had gross proceeds of $1,316,305.52. The planned sale is in accordance with a trading plan adopted on 08/25/2023.
Vertex Pharmaceuticals Inc. officer Bastiano Sanna is set to sell 4,002 shares of common stock on 02/20/2024, with an aggregate market value of approximately $1,684,001.58. The shares to be sold were recently acquired on 02/17/2024 as part of compensation in the form of performance shares and restricted stock vesting, both from the issuer. This transaction follows a previous sale of 3,145 shares within the past three months, which had gross proceeds of $1,316,305.52. The planned sale is in accordance with a trading plan adopted on 08/25/2023.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more